Delivering on the promise of genomic testing in cancer

Foundation Medicine, a US company specializing in genomic analysis diagnostics in oncology, looks at how advances in genomics have changed how we treat cancer, in an Expert View piece.

Increasingly, oncologists are beginning to classify tumors not in terms of the organs in which they originate - lung, breast, liver, pancreas - but instead by changes in specific genes, like EGFR, BRAF or ALK. This has allowed us to identify new drug targets and develop treatments that not only offer a more precise therapy, but which may be effective across cancer types that share a similar genetic signature.

Changing the treatment paradigm